Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PRALSETINIB vs PRAZIQUANTEL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PRALSETINIB vs PRAZIQUANTEL: Safety Overview

Metric PRALSETINIB PRAZIQUANTEL
Total FAERS Reports 1,419 151
Deaths Reported 226 12
Death Rate 15.9% 7.9%
Hospitalizations 431 42
Average Patient Age 61.9 yrs 36.6 yrs
% Female Patients 56.6% 42.8%
FDA Approval Date Sep 4, 2020 Dec 29, 1982
Manufacturer Genentech, Inc. Bayer HealthCare Pharmaceuticals Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued